Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2025)

Historic Inventory Average for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $44.8 million.

  • Kiniksa Pharmaceuticals International's Inventory Average rose 4098.18% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 4098.18%. This contributed to the annual value of $28.7 million for FY2024, which is 903.81% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Inventory Average stood at $44.8 million for Q3 2025, which was up 4098.18% from $35.1 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Inventory Average high stood at $44.8 million for Q3 2025, and its period low was $4.3 million during Q2 2021.
  • Moreover, its 5-year median value for Inventory Average was $24.0 million (2023), whereas its average is $22.1 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 29025.97% in 2022, then crashed by 1706.68% in 2025.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Inventory Average stood at $4.6 million in 2021, then skyrocketed by 290.26% to $18.1 million in 2022, then skyrocketed by 56.56% to $28.4 million in 2023, then dropped by 2.93% to $27.5 million in 2024, then skyrocketed by 62.74% to $44.8 million in 2025.
  • Its Inventory Average was $44.8 million in Q3 2025, compared to $35.1 million in Q2 2025 and $24.2 million in Q1 2025.